$257 Million is the total value of Integral Health Asset Management, LLC's 50 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| A | New | AGILENT TECHNOLOGIES INC | $14,503,000 | – | 170,000 | +100.0% | 5.65% | – |
| DXCM | New | DEXCOM INC | $13,124,000 | – | 60,000 | +100.0% | 5.11% | – |
| BMY | New | BRISTOL MYERS SQUIBB CO | $12,196,000 | – | 190,000 | +100.0% | 4.75% | – |
| MDT | New | MEDTRONIC PLC | $11,912,000 | – | 105,000 | +100.0% | 4.64% | – |
| AMED | New | AMEDISYS INC | $10,850,000 | – | 65,000 | +100.0% | 4.22% | – |
| SNY | New | SANOFIsponsored adr | $9,538,000 | – | 190,000 | +100.0% | 3.71% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $9,301,000 | – | 110,000 | +100.0% | 3.62% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $9,073,000 | – | 190,000 | +100.0% | 3.53% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $9,044,000 | – | 200,000 | +100.0% | 3.52% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $8,663,000 | – | 120,000 | +100.0% | 3.37% | – |
| DGX | New | QUEST DIAGNOSTICS INC | $8,543,000 | – | 80,000 | +100.0% | 3.33% | – |
| VAR | New | VARIAN MED SYS INC | $8,521,000 | – | 60,000 | +100.0% | 3.32% | – |
| HUM | New | HUMANA INC | $8,430,000 | – | 23,000 | +100.0% | 3.28% | – |
| ABBV | New | ABBVIE INC | $8,411,000 | – | 95,000 | +100.0% | 3.28% | – |
| TFX | New | TELEFLEX INC | $7,905,000 | – | 21,000 | +100.0% | 3.08% | – |
| CNC | New | CENTENE CORP DEL | $7,859,000 | – | 125,000 | +100.0% | 3.06% | – |
| CVS | New | CVS HEALTH CORP | $7,429,000 | – | 100,000 | +100.0% | 2.89% | – |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $6,614,000 | – | 345,000 | +100.0% | 2.58% | – |
| LLY | New | LILLY ELI & CO | $6,572,000 | – | 50,000 | +100.0% | 2.56% | – |
| NUVA | New | NUVASIVE INC | $6,187,000 | – | 80,000 | +100.0% | 2.41% | – |
| GH | New | GUARDANT HEALTH INC | $5,470,000 | – | 70,000 | +100.0% | 2.13% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $4,406,000 | – | 200,000 | +100.0% | 1.72% | – |
| SWAV | New | SHOCKWAVE MED INC | $3,953,000 | – | 90,000 | +100.0% | 1.54% | – |
| QURE | New | UNIQURE NV | $3,941,000 | – | 55,000 | +100.0% | 1.54% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $3,752,000 | – | 175,000 | +100.0% | 1.46% | – |
| SGEN | New | SEATTLE GENETICS INC | $3,428,000 | – | 30,000 | +100.0% | 1.34% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $3,179,000 | – | 70,000 | +100.0% | 1.24% | – |
| BLUE | New | BLUEBIRD BIO INC | $3,071,000 | – | 35,000 | +100.0% | 1.20% | – |
| BHC | New | BAUSCH HEALTH COS INC | $2,992,000 | – | 100,000 | +100.0% | 1.16% | – |
| ZYME | New | ZYMEWORKS INC | $2,955,000 | – | 65,000 | +100.0% | 1.15% | – |
| THC | New | TENET HEALTHCARE CORP | $2,852,000 | – | 75,000 | +100.0% | 1.11% | – |
| MYL | New | MYLAN N V | $2,613,000 | – | 130,000 | +100.0% | 1.02% | – |
| NVO | New | NOVO-NORDISK A Sadr | $2,315,000 | – | 40,000 | +100.0% | 0.90% | – |
| INCY | New | INCYTE CORP | $2,183,000 | – | 25,000 | +100.0% | 0.85% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $2,091,000 | – | 20,000 | +100.0% | 0.81% | – |
| CI | New | CIGNA CORP NEW | $2,045,000 | – | 10,000 | +100.0% | 0.80% | – |
| CCXI | New | CHEMOCENTRYX INC | $1,978,000 | – | 50,000 | +100.0% | 0.77% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $1,933,000 | – | 15,000 | +100.0% | 0.75% | – |
| TXG | New | 10X GENOMICS INC | $1,906,000 | – | 25,000 | +100.0% | 0.74% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $1,674,000 | – | 50,000 | +100.0% | 0.65% | – |
| BMYRT | New | BRISTOL MYERS SQUIBB COright 99/99/9999 | $1,656,000 | – | 550,000 | +100.0% | 0.64% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $1,619,000 | – | 75,000 | +100.0% | 0.63% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $1,612,000 | – | 15,000 | +100.0% | 0.63% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $1,602,000 | – | 20,000 | +100.0% | 0.62% | – |
| HOLX | New | HOLOGIC INC | $1,566,000 | – | 30,000 | +100.0% | 0.61% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $1,362,000 | – | 20,000 | +100.0% | 0.53% | – |
| NERV | New | MINERVA NEUROSCIENCES INC | $1,280,000 | – | 180,000 | +100.0% | 0.50% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $1,072,000 | – | 35,000 | +100.0% | 0.42% | – |
| GOSS | New | GOSSAMER BIO INC | $938,000 | – | 60,000 | +100.0% | 0.36% | – |
| DTIL | New | PRECISION BIOSCIENCES INC | $695,000 | – | 50,000 | +100.0% | 0.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.